These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17848614)

  • 1. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
    Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
    Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study.
    Cheung BM; Wat NM; Man YB; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Diabetes Care; 2007 Jun; 30(6):1430-6. PubMed ID: 17337491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Stroke; 2008 Apr; 39(4):1078-83. PubMed ID: 18323501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
    J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
    Pambianco G; Costacou T; Orchard TJ
    Diabetes Care; 2007 May; 30(5):1248-54. PubMed ID: 17303788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
    Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.